chr16-21687628-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_144672.4(OTOA):​c.615C>T​(p.Arg205Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0352 in 1,611,076 control chromosomes in the GnomAD database, including 1,206 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.034 ( 105 hom., cov: 31)
Exomes 𝑓: 0.035 ( 1101 hom. )

Consequence

OTOA
NM_144672.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.63

Publications

5 publications found
Variant links:
Genes affected
OTOA (HGNC:16378): (otoancorin) The protein encoded by this gene is specifically expressed in the inner ear, and is located at the interface between the apical surface of the inner ear sensory epithelia and their overlying acellular gels. It is prposed that this protein is involved in the attachment of the inner ear acellular gels to the apical surface of the underlying nonsensory cells. Mutations in this gene are associated with autosomal recessive deafness type 22 (DFNB22). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
OTOA Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 22
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 16-21687628-C-T is Benign according to our data. Variant chr16-21687628-C-T is described in ClinVar as Benign. ClinVar VariationId is 47955.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.63 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0608 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOANM_144672.4 linkc.615C>T p.Arg205Arg synonymous_variant Exon 8 of 29 ENST00000646100.2 NP_653273.3
OTOANM_001161683.2 linkc.378C>T p.Arg126Arg synonymous_variant Exon 3 of 24 NP_001155155.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOAENST00000646100.2 linkc.615C>T p.Arg205Arg synonymous_variant Exon 8 of 29 NM_144672.4 ENSP00000496564.2

Frequencies

GnomAD3 genomes
AF:
0.0339
AC:
5100
AN:
150456
Hom.:
105
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0284
Gnomad AMI
AF:
0.0187
Gnomad AMR
AF:
0.0409
Gnomad ASJ
AF:
0.0257
Gnomad EAS
AF:
0.00157
Gnomad SAS
AF:
0.0101
Gnomad FIN
AF:
0.0367
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0393
Gnomad OTH
AF:
0.0439
GnomAD2 exomes
AF:
0.0305
AC:
7640
AN:
250478
AF XY:
0.0310
show subpopulations
Gnomad AFR exome
AF:
0.0266
Gnomad AMR exome
AF:
0.0273
Gnomad ASJ exome
AF:
0.0312
Gnomad EAS exome
AF:
0.00142
Gnomad FIN exome
AF:
0.0349
Gnomad NFE exome
AF:
0.0408
Gnomad OTH exome
AF:
0.0388
GnomAD4 exome
AF:
0.0354
AC:
51649
AN:
1460578
Hom.:
1101
Cov.:
34
AF XY:
0.0349
AC XY:
25375
AN XY:
726592
show subpopulations
African (AFR)
AF:
0.0299
AC:
1001
AN:
33452
American (AMR)
AF:
0.0279
AC:
1245
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.0305
AC:
796
AN:
26108
East Asian (EAS)
AF:
0.00807
AC:
320
AN:
39666
South Asian (SAS)
AF:
0.0113
AC:
970
AN:
86216
European-Finnish (FIN)
AF:
0.0355
AC:
1891
AN:
53314
Middle Eastern (MID)
AF:
0.0664
AC:
365
AN:
5498
European-Non Finnish (NFE)
AF:
0.0386
AC:
42847
AN:
1111346
Other (OTH)
AF:
0.0367
AC:
2214
AN:
60298
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
2587
5174
7761
10348
12935
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1540
3080
4620
6160
7700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0339
AC:
5104
AN:
150498
Hom.:
105
Cov.:
31
AF XY:
0.0346
AC XY:
2542
AN XY:
73384
show subpopulations
African (AFR)
AF:
0.0285
AC:
1166
AN:
40946
American (AMR)
AF:
0.0409
AC:
617
AN:
15104
Ashkenazi Jewish (ASJ)
AF:
0.0257
AC:
89
AN:
3464
East Asian (EAS)
AF:
0.00157
AC:
8
AN:
5094
South Asian (SAS)
AF:
0.0103
AC:
49
AN:
4750
European-Finnish (FIN)
AF:
0.0367
AC:
370
AN:
10086
Middle Eastern (MID)
AF:
0.102
AC:
29
AN:
284
European-Non Finnish (NFE)
AF:
0.0394
AC:
2669
AN:
67798
Other (OTH)
AF:
0.0436
AC:
90
AN:
2064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
240
480
721
961
1201
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0381
Hom.:
208
Bravo
AF:
0.0335
Asia WGS
AF:
0.0110
AC:
37
AN:
3478
EpiCase
AF:
0.0465
EpiControl
AF:
0.0475

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Arg205Arg in Exon 07 of OTOA: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 3.7% (263/7020) of Eu ropean American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs16972658). -

Oct 13, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:3
Dec 31, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.20
DANN
Benign
0.45
PhyloP100
-2.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16972658; hg19: chr16-21698949; COSMIC: COSV53751991; API